Vimarsana
Biggest News Aggregation in the World

Page 3 - Mark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Diagnostics Today - Breaking & Trending Today

Oncology Molecular Diagnostic Market Size to Reach USD 11.45 Billion Globally with Growing CAGR of 1 - Vimarsana News

Oncology Molecular Diagnostic Market Size to Reach USD 11.45 Billion Globally with Growing CAGR of 1

Global Oncology Molecular Diagnostic Market report is generated by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. With this report, businesses can get clear idea about how the market is going to perform in the forecast years with understan...

BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting - Vimarsana News

BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting

BioMark Diagnostics Inc. , an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers, is pleased to announce that its latest leading-edge research was presented... | June 5, 2023

BioMark Diagnostics, Inc.: BioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assay - Vimarsana News

BioMark Diagnostics, Inc.: BioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assay

The new family of patent granted by USPTO strengthens BioMark's global intellectual property position in liquid biopsy and early cancer detection Vancouver, British Columbia--(Newsfile Corp. - May 31

BioMark Diagnostics, Inc.: BioMark Latest Results Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023 - Vimarsana News

BioMark Diagnostics, Inc.: BioMark Latest Results Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023

New analyses from a large retrospective validation study of early lung cancer metabolomics panel, underscoring strength of BioMark's liquid biopsy platform, to be presented. Vancouver, British Columbia--(Newsfile

Global COVID-19 Testing Strategic Business Report 2023: U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Decrease by 30.7% CAGR to 2030 - Vimarsana News

Global COVID-19 Testing Strategic Business Report 2023: U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Decrease by 30.7% CAGR to 2030

/PRNewswire/ -- The "COVID-19 Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global COVID-19 Testing...